Detalhe da pesquisa
1.
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists.
Bioorg Med Chem
; 26(9): 2229-2250, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459145
2.
Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF1 receptor antagonist.
Bioorg Med Chem
; 25(5): 1556-1570, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28174066
3.
Discovery of a 7-arylaminobenzimidazole series as novel CRF1 receptor antagonists.
Bioorg Med Chem
; 24(19): 4675-4691, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27567079
4.
TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies.
Cancer Res Commun
; 2(6): 489-502, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923556
5.
Discovery of pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor.
Bioorg Med Chem Lett
; 21(8): 2365-71, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21414781
6.
Design and Synthesis of Benzimidazoles As Novel Corticotropin-Releasing Factor 1 Receptor Antagonists.
J Med Chem
; 59(6): 2551-66, 2016 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26901666